NCT03753087: Effects of Empagliflozin on Exercise Capacity and Left Ventricular Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction and Type-2 Diabetes Mellitus
- State
- Completed
- Phase
- Phase 4
- People
- 70 taking part
- Started
- 16 Jan 2019
- Primary completion
- 16 Dec 2021
- Arms
- Empagliflozin
- Results
- None posted
- 26 Nov 2018: Trial registered
- 16 Jan 2019: Trial started
- 10 Jan 2022: Trial completed